What is the price target for JAGX stock?
7 analysts have analysed JAGX and the average price target is 16.32 USD. This implies a price increase of 5726.49% is expected in the next year compared to the current price of 0.2801.
JAGUAR HEALTH INC (JAGX) Forecast, Price Target & Analyst Ratings
NASDAQ:JAGX • US47010C8881
Current stock price
0.2801 USD
-0.11 (-27.77%)
At close:
0.28 USD
0 (-0.04%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for JAGUAR HEALTH INC (JAGX).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$2.08
- Revenue Estimate
- 3.741M
Price Target Details & History
Consensus Price Target and Range
Mean target
$16.32
Upside
+ 5,726.49%
From current price of $0.28 to mean target of $16.32, Based on 7 analyst forecasts
Low
$16.16
Median
$16.32
High
$16.80
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for JAGX. The average price target is 16.32 USD. This implies a price increase of 5726.49% is expected in the next year compared to the current price of 0.2801.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.71%
JAGX was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about JAGX.
In the previous month the buy percentage consensus was at a similar level.
JAGX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-05-19 | First Berlin | Initiate | Buy |
| 2021-07-07 | Cantor Fitzgerald | Initiate | Overweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$2.08
- Revenue Estimate
- 3.741M
- Revenue Q2Q
- 68.97%
- EPS Q2Q
- 87.54%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
JAGX is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -2.08 USD and the consensus revenue estimate is 3.74M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2026 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.761M -18.36% | 11.689M 19.75% | 11.511M -1.52% | 18.6M 61.58% | 204M 996.77% | 389.44M 90.90% | 573.95M 47.38% | 682.99M 19.00% | |
| EBITDA YoY % growth | -31.907M 1.62% | -28.931M 9.33% | -43.195M -49.30% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -33.92M 1.44% | -30.831M 9.11% | -45.108M -46.31% | -23.633M 47.61% | 105.67M 547.12% | 260.3M 146.33% | 415.85M 59.76% | 509.49M 22.52% | |
| Operating Margin | -347.51% | -263.76% | -391.87% | -127.06% | 51.80% | 66.84% | 72.45% | 74.60% | |
| EPS YoY % growth | N/A 89.90% | -232.59 -3,811.31% | N/A 89.56% | -5.79 76.14% | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -2.08 87.54% | -1.52 85.19% | -1.19 81.00% | -1.30 70.19% |
| Revenue Q2Q % growth | 3.741M 68.97% | 4.33M 47.48% | 4.945M 60.40% | 5.583M 72.58% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.62M 40.34% | -5.467M 31.72% | -5.375M 25.73% | -7.181M 64.87% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
200.81%
Revenue Next 5 Year
116.65%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
JAGUAR HEALTH INC / JAGX Forecast FAQ
When does JAGUAR HEALTH INC (JAGX) report earnings?
JAGUAR HEALTH INC (JAGX) will report earnings on 2026-05-13.
What are the consensus estimates for JAGUAR HEALTH INC (JAGX) next earnings?
The consensus EPS estimate for the next earnings of JAGUAR HEALTH INC (JAGX) is -2.08 USD and the consensus revenue estimate is 3.74M USD.
How many analysts cover JAGUAR HEALTH INC (JAGX) stock?
The number of analysts covering JAGUAR HEALTH INC (JAGX) is 7.